Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease

Systemic and local inflammation plays a prominent role in the pathogenesis of atherosclerotic coronary artery disease, but the relationship of whole blood gene expression changes with coronary disease remains unclear. We have investigated whether gene expression patterns in peripheral blood correlate with the severity of coronary disease and whether these patterns correlate with the extent of atherosclerosis in the vascular wall. Patients were selected according to their coronary artery disease index (CADi), a validated angiographical measure of the extent of coronary atherosclerosis that correlates with outcome. RNA was extracted from blood of 120 patients with at least a stenosis greater than 50% (CADi≥23) and from 121 controls without evidence of coronary stenosis (CADi = 0). 160 individual genes were found to correlate with CADi (rho>0.2, P<0.003). Prominent differential expression was observed especially in genes involved in cell growth, apoptosis and inflammation. Using these 160 genes, a partial least squares multivariate regression model resulted in a highly predictive model (r2 = 0.776, P<0.0001). The expression pattern of these 160 genes in aortic tissue also predicted the severity of atherosclerosis in human aortas, showing that peripheral blood gene expression associated with coronary atherosclerosis mirrors gene expression changes in atherosclerotic arteries. In conclusion, the simultaneous expression pattern of 160 genes in whole blood correlates with the severity of coronary artery disease and mirrors expression changes in the atherosclerotic vascular wall.

[1]  T. Kodama,et al.  Global analysis of RNA expression profile in human vascular cells treated with statins. , 2004, Journal of atherosclerosis and thrombosis.

[2]  J. Soria,et al.  Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL‐4, IL‐10 and IL‐13: consequences on cell adhesion to vitronectin and fibrinogen , 1998, British journal of haematology.

[3]  J. Epstein,et al.  Detection of Cardiac Allograft Rejection and Response to Immunosuppressive Therapy With Peripheral Blood Gene Expression , 2004, Circulation.

[4]  G. Lanfranchi,et al.  Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. , 2006, Journal of molecular and cellular cardiology.

[5]  M. Mattei,et al.  Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[7]  S. You,et al.  Ferritin in atherosclerosis. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[8]  S. Goerdt,et al.  Stabilin‐1 localizes to endosomes and the trans‐Golgi network in human macrophages and interacts with GGA adaptors , 2004, Journal of leukocyte biology.

[9]  C. O'connor,et al.  A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.

[10]  J. Pankow,et al.  Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. , 2005, American journal of hypertension.

[11]  Geoffrey S Ginsburg,et al.  Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis , 2008, Circulation. Cardiovascular genetics.

[12]  A. Zaas,et al.  Peripheral blood gene expression profiling for cardiovascular disease assessment , 2007, Genomic Medicine.

[13]  V. Heath,et al.  C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo , 2004 .

[14]  C. Grimaldi,et al.  Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement , 2003, Journal of leukocyte biology.

[15]  P. Libby,et al.  CD40 Signaling and Plaque Instability , 2001, Circulation research.

[16]  P. O'Malley,et al.  C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. , 2001, American heart journal.

[17]  Mark Gurney,et al.  The gene encoding phosphodiesterase 4D confers risk of ischemic stroke , 2003, Nature Genetics.

[18]  A. Folsom,et al.  Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. , 2001, International journal of epidemiology.

[19]  Kaiyu Jiang,et al.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis , 2003, Arthritis research & therapy.

[20]  F. Harrell,et al.  Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.

[21]  J. Larosa,et al.  Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. , 1985, The American journal of cardiology.

[22]  Yulian Wu,et al.  Ephrin B2 Induces T Cell Costimulation1 , 2003, The Journal of Immunology.

[23]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[24]  M. Lennon,et al.  Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis , 2003, Journal of thrombosis and haemostasis : JTH.

[25]  P. Törönen,et al.  Changes in gene expression in atherosclerotic plaques analyzed using DNA array. , 2002, Atherosclerosis.

[26]  M. Kaste,et al.  Microarray Analysis Reveals Overexpression of CD163 and HO-1 in Symptomatic Carotid Plaques , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Piek,et al.  Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. , 2009, Journal of molecular and cellular cardiology.

[28]  J. Rotter,et al.  Genetic markers: progress and potential for cardiovascular disease. , 2004, Circulation.

[29]  P. Rizzon,et al.  Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype , 2003, Journal of hypertension.

[30]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[31]  G. Baillie,et al.  Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte‐macrophage differentiation of human U937 cells , 2004, British journal of pharmacology.

[32]  B. Horne,et al.  C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. , 2002, Journal of the American College of Cardiology.

[33]  E. Topol,et al.  Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. , 2003, Physiological genomics.

[34]  Denis Hochstrasser,et al.  Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. , 2006, American heart journal.

[35]  D. Arvanitis,et al.  Genomic rearrangements on VCAM1, SELE, APEG1 and AIF1 loci in atherosclerosis , 2005, Journal of cellular and molecular medicine.

[36]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[37]  Bing Liu,et al.  Smad5: signaling roles in hematopoiesis and osteogenesis. , 2004, The international journal of biochemistry & cell biology.

[38]  J. Neaton,et al.  Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. , 1985, JAMA.

[39]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[40]  V. Heath,et al.  C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. , 2004, Blood.

[41]  P. Detloff,et al.  Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization. , 2000, Gene.

[42]  M. West,et al.  Gene Expression Phenotypes of Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[43]  R. Wilensky,et al.  Site-Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[44]  K. Heeg,et al.  Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Javed Khan,et al.  Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. , 2003, Human molecular genetics.

[46]  Nilesh J Samani,et al.  Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. , 2004, European heart journal.

[47]  R. Andreesen,et al.  Expression of retinoid receptors during human monocyte differentiation in vitro. , 2000, Biochemical and biophysical research communications.

[48]  M. Gladwin,et al.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.

[49]  L. Lindbom,et al.  Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  R. Latorre,et al.  Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. , 2004, The Journal of clinical investigation.

[51]  C. Tribioli,et al.  An X chromosome-linked gene encoding a protein with characteristics of a rhoGAP predominantly expressed in hematopoietic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Alcorta,et al.  Microarray Studies of Gene Expression in Circulating Leukocytes in Kidney Diseases , 2002, Nephron Experimental Nephrology.

[53]  W. Koenig,et al.  Utility of inflammatory markers in the management of coronary artery disease. , 2003, The American journal of cardiology.

[54]  M. Daemen,et al.  Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. , 2007, Physiological genomics.

[55]  Hafiz M. R. Khan,et al.  Optimizing RNA extraction yield from whole blood for microarray gene expression analysis. , 2004, Clinical biochemistry.

[56]  W. Zimmermann,et al.  Pregnancy‐Specific Glycoproteins Function as Immunomodulators by Inducing Secretion of IL‐10, IL‐6 and TGF‐β1 by Human Monocytes , 2001, American journal of reproductive immunology.

[57]  G. Lanfranchi,et al.  Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries , 2009, BMC Genomics.

[58]  M. J. Abedin,et al.  Potential roles of galectins in myeloid differentiation into three different lineages , 2003, Journal of leukocyte biology.

[59]  L. Citterio,et al.  Role of the adducin family genes in human essential hypertension , 2005, Journal of Hypertension.

[60]  J. Kaski,et al.  C-reactive protein elevation and disease activity in patients with coronary artery disease. , 2004, European heart journal.

[61]  Jaw-Wen Chen,et al.  Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X. , 2003, International journal of cardiology.

[62]  R. Moqbel,et al.  Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. , 2003, The Journal of allergy and clinical immunology.